The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | Common | 004225108 | 42,870 | 1,486,460 | SH | SOLE | 1,486,460 | 0 | 0 | ||
| ACADIA PHARMACEUTICALS INC | Common | 004225108 | 283 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| ACADIA PHARMACEUTICALS INC | Common | 004225108 | 130 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| AERIE PHARMACEUTICALS INC | Common | 00771V108 | 23,089 | 610,000 | SH | SOLE | 610,000 | 0 | 0 | ||
| AGENUS INC | Common | 00847G705 | 15,452 | 3,750,430 | SH | SOLE | 3,750,430 | 0 | 0 | ||
| AGENUS INC | Common | 00847G705 | 25 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
| AKEBIA THERAPEUTICS INC | Common | 00972D105 | 8,656 | 831,515 | SH | SOLE | 831,515 | 0 | 0 | ||
| ALEXION PHARMACEUTICALS INC | Common | 015351109 | 20,800 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | ||
| ALIMERA SCIENCES INC | Common | 016259103 | 4,357 | 4,034,488 | SH | SOLE | 4,034,488 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 19,967 | 4,017,577 | SH | SOLE | 4,017,577 | 0 | 0 | ||
| ARRAY BIOPHARMA INC | Common | 04269X105 | 1,406 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
| ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 11,035 | 545,203 | SH | SOLE | 545,203 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | Common | 045396108 | 3,284 | 270,289 | SH | SOLE | 270,289 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS INC | Common | 09058V103 | 10,327 | 1,631,502 | SH | SOLE | 1,631,502 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL INC | Common | 09060J106 | 1,127 | 644,176 | SH | SOLE | 644,176 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 33,136 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| BRISTOL MYERS SQUIBB CO. | Common | 110122108 | 16,655 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | ||
| CASCADIAN THERAPEUTICS INC | Common | 14740B606 | 3,971 | 921,248 | SH | SOLE | 921,248 | 0 | 0 | ||
| CATALYST PHARMACEUTICALS INC | Common | 14888U101 | 1,198 | 1,141,149 | SH | SOLE | 1,141,149 | 0 | 0 | ||
| CELLECTIS - ADR | Sponsored ADR | 15117K103 | 1,646 | 97,096 | SH | SOLE | 97,096 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | Common | 221015100 | 3,098 | 216,619 | SH | SOLE | 216,619 | 0 | 0 | ||
| DERMIRA INC | Common | 24983L104 | 23,224 | 765,709 | SH | SOLE | 765,709 | 0 | 0 | ||
| FORTRESS BIOTECH INC | Common | 34960Q109 | 3,241 | 1,200,342 | SH | SOLE | 1,200,342 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS INC | Common | 37890U108 | 14,390 | 995,838 | SH | SOLE | 995,838 | 0 | 0 | ||
| IMMUNOMEDICS INC | Common | 452907108 | 33,996 | 9,263,340 | SH | SOLE | 9,263,340 | 0 | 0 | ||
| IMMUNOMEDICS INC | Common | 452907108 | 23 | 300,800 | SH | Call | SOLE | 300,800 | 0 | 0 | |
| LION BIOTECHNOLOGIES INC | Common | 53619R102 | 31,418 | 4,520,643 | SH | SOLE | 4,520,643 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | Common | 60468T105 | 7,164 | 1,508,201 | SH | SOLE | 1,508,201 | 0 | 0 | ||
| NEUROCRINE BIOSCIENCES INC | Common | 64125C109 | 20,937 | 541,000 | SH | SOLE | 541,000 | 0 | 0 | ||
| NEURODERM LTD | Common | M74231107 | 23,450 | 1,056,303 | SH | SOLE | 1,056,303 | 0 | 0 | ||
| ONCOBIOLOGICS INC | Common | 68235M105 | 2,057 | 683,531 | SH | SOLE | 683,531 | 0 | 0 | ||
| ONCOBIOLOGICS INC - WARRANT A | Warrant | 68235M113 | 44 | 233,333 | SH | SOLE | 233,333 | 0 | 0 | ||
| ONCOBIOLOGICS INC - WARRANT B | Warrant | 68235M121 | 184 | 233,333 | SH | SOLE | 233,333 | 0 | 0 | ||
| PERNIX THERAPEUTICS HOLDINGS INC | Convertible Debt | 71426VAK4 | 1,479 | 6,000,000 | PRN | SOLE | 6,000,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | Common | 803607100 | 615 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | |
| SAREPTA THERAPEUTICS INC | Common | 803607100 | 27,713 | 1,010,300 | SH | SOLE | 1,010,300 | 0 | 0 | ||
| SEATTLE GENETICS INC | Common | 812578102 | 15,595 | 295,533 | SH | SOLE | 295,533 | 0 | 0 | ||
| SORRENTO THERAPEUTICS INC | Common | 83587F202 | 7,135 | 1,456,056 | SH | SOLE | 1,456,056 | 0 | 0 | ||
| TELIGENT INC | Common | 87960W104 | 10,997 | 1,663,619 | SH | SOLE | 1,663,619 | 0 | 0 | ||
| TESARO INC | Common | 881569107 | 31,159 | 231,700 | SH | SOLE | 231,700 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | Common | 89620X506 | 1,285 | 227,399 | SH | SOLE | 227,399 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | Common | 921659108 | 6,084 | 381,466 | SH | SOLE | 381,466 | 0 | 0 | ||
| VERACYTE INC | Common | 92337F107 | 7,020 | 906,999 | SH | SOLE | 906,999 | 0 | 0 | ||
| XENCOR INC | Common | 98401F105 | 3,290 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||